openPR Logo
Press release

Ocimum Biosolutions develops Sulfolobus solfataricus microarrays for SulfoSYS

06-01-2010 02:46 PM CET | Science & Education

Press release from: Ocimum biosolutions

Ocimum Biosolutions develops Sulfolobus solfataricus

Hyderabad, Andhra Pradesh, India, May 31, 2010: Ocimum Biosolutions, a leading global integrated genomics company, proudly announces its association with the SulfoSYS project (sulfosys.com).

In a project coordinated by Prof. John van der Oost, Ocimum Biosolutions constructed the genome microarray for Sulfolobus solfataricus – the archaeal model organism of choice for a systems biology approach to study the evolution and characteristics of central cellular functions in living cells.

Prof. John van der Oost said “We have very good experience with the mentioned microarrays, and we and other members of the Solfolobus Chip consortium were impressed by the quality of the slides provided.”

Ms. Anu Acharya, CEO of Ocimum Biosolutions said “For esteemed researchers like Prof. John van der Oost, who want to target specific genes, or small genomes, our OciChip™ custom microarrays have become the platform of choice. These cost-effective microarrays can be used on all open array platforms, unlike other proprietary technologies. In addition, our sophisticated bioinformatics expertise results in highly sensitive and specific microarrays. These twin benefits have helped us become the preferred partner of consortia like SulfoSYS.”

About SulfoSYS
In the SulfoSYS project, within the transnational SysMO initiative (http://www.sysmo.net/), 10 European partners study the central carbohydrate metabolism (CCM), i.e. the branched ED pathway of S. solfataricus and its regulation under temperature variation by the integration of genomic, transcriptomic, proteomic, metabolomic, kinetic and biochemical information as well as modeling. The long term goal of the project is to build a sufficiently precise replica for this part of the living cell “a Silicon Cell” to enable computation of life, particular its robustness to changes in temperature, at the system level. For more information, please visit http://www.sulfosys.com.


About OciChip™ Custom Microarrays
OciChip™ Custom microarrays are epoxy-coated glass slides onto which the sequences from thousands of different genes are immobilized, or attached, at fixed locations. First, for each gene of interest, 50 to 70 mer oligonucleotides are bioinformatically designed excluding dimers and, secondary structure formation, thereby ensuring highly reproducible hybridization achieved by precisely defined GC-content/melting temperature. Then, based on the researcher’s study objective, the layout of these oligonucleotides on the microarray is bioinformatically designed with maximal reduction of cross-hybridization & avoiding background contamination. The oligonucleotides are then synthesized and QCed using mass-spectrometry. These oligonucleotides are then mechanically micro-spotted on the epoxy-coated glass slides.
Note: Apart from oligonucleotides, Ocimum also spots genomic DNA clones, cDNA, proteins, peptides, lipids, carbohydrates, and other small molecules.
For more information, write to europe@ocimumbio.com or visit http://www3.ocimumbio.com/laboratory-sample-data-management/research-consumables/microarrays/

About Ocimum Biosolutions
Ocimum Biosolutions is a global integrated genomic services company with operations in Hyderabad, India and Gaithersburg, MD. We provide comprehensive (research level and GLP-compliant) genomic services, reference databases, and LIMS solutions. Our distinct platform "Research as a Service" (RaaS) allows complete outsourcing of genomics – from storing biological samples and performing on demand DNA and RNA based services to validating biomarkers using our proprietary databases and providing data and bioinformatic analysis. We have been chosen as a global preferred outsourcing provider for more than 75% of top 25 phama and biotech companies plus leading research institutes. Our partners recognize our expertise for understanding disease mechanisms in correlation with discovery, prioritization of gene targets and biomarkers, and sample analysis for clinical studies.

For more information, please visit www.ocimumbio.com

Dhanya Menon
Communication Manager
6th floor Reliance classic, Road No 1, Banjara Hills
Hyderabad, Andhra Pradesh 500034 India
040 66986700
Email: dhanya.m@ocimumbio.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Ocimum Biosolutions develops Sulfolobus solfataricus microarrays for SulfoSYS here

News-ID: 133519 • Views:

More Releases from Ocimum biosolutions

Ocimum Biosolutions Wins 2012 Customer Value Enhancement Award for Lab Informati …
Hyderabad, India, October 10, 2012: Ocimum Biosolutions won the Customer Value Enhancement Award for Laboratory Information Management in India, at the 2012 Frost & Sullivan Indian Growth, Innovation & Leadership Awards Banquet held in Mumbai on October 9, 2012. The award is a recognition of Ocimum’s accomplishments in the domain of Laboratory Information Management Systems (LIMS) development. For their popular and internationally acclaimed flagship product Biotracker™, this award is expected
Gene Logic Launches new user-friendly ASCENTA 4.0 with improved functionality
Gene Logic today announced the release of ASCENTA System Version 4.0, which incorporates a number of significant changes in functionality reinforcing its position as a valuable research tool to the academic, biotechnology and pharmaceutical markets. ASCENTA is a reference software product for use in gene expression studies. In the continuous quest to improve accessibility and provide the most comprehensive data for researchers, Gene Logic has launched this newest version, ASCENTA 4.0.
Ocimum closes $8 million to fuel future growth
Gaithersburg, Maryland, US and Hyderabad, Andhra Pradesh, India, 9th Dec 2010 Ocimum Biosolutions today announced its growth plans after having closed funding worth $ 8.0 million from multiple sources, including founders and existing shareholders, in order to cater to the growing demand for its integrated genomic services and to provide unparalleled, hassle-free user experience by enhancing its RaaS (Research as a Service) platform. The company is in the process of building

All 4 Releases